Foxo Technologies Inc. Warrant (FOXOW)

Market Open

3 Jun, 20:00

OTC PINK

0. 01

-0.02

-60%

- Market Cap

- P/E Ratio

0% Div Yield

10,000 Volume

0 Eps

$ 0.03

Previous Close

Day Range

0.01 0.01

Year Range

0 0.06

Summary

FOXOW trading today lower at $0.01, a decrease of 60% from yesterday's close, completing a monthly decrease of -28.57% or $0. Over the past 12 months, FOXOW stock lost -60%.

FOXOW is not paying dividends to its shareholders.

The stock of the company had never split.

The company's stock is traded on 1 different exchanges and in various currencies, with the primary listing on OTC PINK (USD).

Want to track FOXOW and more in your Portfolio? 🎯

Get Started For Free

FOXOW Chart

Foxo Technologies Inc. Warrant Dividends

FOXOW is not paying dividends to its shareholders.

Foxo Technologies Inc. Warrant Earnings

FOXOW have yet to publish their earning reports.

Dividends
Earnings

FOXOW is not paying dividends to its shareholders.

FOXOW have yet to publish their earning reports.

Foxo Technologies Inc. Warrant (FOXOW) FAQ

What is the stock price today?

The current price is $0.01.

On which exchange is it traded?

Foxo Technologies Inc. Warrant is listed on OTC PINK.

What is its stock symbol?

The ticker symbol is FOXOW.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, no market cap data is available.

Has Foxo Technologies Inc. Warrant ever had a stock split?

No, there has never been a stock split.

Foxo Technologies Inc. Warrant Profile

Medical - Healthcare Information Services Industry	Healthcare Sector	Mr. Seamus Lagan CEO	OTC PINK Exchange	- ISIN
US Country	102 Employees	- Last Dividend	- Last Split	29 Jan 2021 IPO Date

Overview

FOXO Technologies Inc. is an innovative company that operates in the field of epigenetic biomarker underwriting technology and consumer engagement platform service within the United States. Founded in 2020 and headquartered in Minneapolis, Minnesota, FOXO Technologies has developed a unique approach by applying automated machine learning and artificial intelligence technologies to discover epigenetic biomarkers associated with human health, wellness, and aging. The company operates through two main segments, FOXO Labs and FOXO Life, focusing on developing cutting-edge solutions for the life insurance industry and beyond. As a subsidiary of FOXO Management LLC, FOXO Technologies Inc. aims to revolutionize the way biomarker solutions are utilized for underwriting and risk assessment in the insurance sector.

Products and Services

FOXO Labs
FOXO Labs is at the forefront of commercializing proprietary epigenetic biomarker technology. This segment focuses on enabling the adoption of saliva-based health and wellness biomarker solutions, which are designed to revolutionize underwriting and risk assessment processes. By leveraging the latest advances in automatic machine learning and artificial intelligence, FOXO Labs aims to provide the insurance industry with innovative tools for assessing policyholder risk based on reliable biomarkers related to health, wellness, and aging.
FOXO Life
FOXO Life represents the company’s sales and distribution platform, which is primarily focused on recruiting independent life insurance agents. These agents are tasked with selling life insurance policies bundled with the Longevity Report. The Longevity Report, a unique feature of FOXO Life products, offers policyholders insights into their health and aging biomarkers, offering a new dimension to traditional life insurance. Through this platform, FOXO Technologies aims to not only enhance the way life insurance is sold but also to encourage a broader conversation around longevity and wellness.

Contact Information

Address: 729 North Washington Avenue

Phone: 612-562-9447

Website: https://www.foxotechnologies.com

Affiliate Program About Report a Bug Terms Privacy Help Contact Us